About 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile
4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile (PubChem CID 155249642) has the molecular formula C15H17N5O2
and a molecular weight of 299.33 g/mol. Its IUPAC name is 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile.
Analyze 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile?
The IUPAC name of 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile (CID 155249642) is 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile.
What is the SMILES notation for 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile?
The canonical SMILES for 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile is COc1cc(-c2cc(CN3CCNCC3)on2)ncc1C#N.
What is the InChIKey of 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile?
The InChIKey is FYTSHIKUOPCWIK-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H17N5O2/c1-21-15-7-13(18-9-11(15)8-16)14-6-12(22-19-14)10-20-4-2-17-3-5-20/h6-7,9,17H,2-5,10H2,1H3.
What are the key properties of 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile?
4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile has a molecular weight of 299.33 g/mol, XLogP of 1.02, 4 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methoxy-6-[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]pyridine-3-carbonitrile is sourced from PubChem (CID 155249642), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).